X Chen

1.6k citations

58 papers · 1.3k indexed · h-index 20

Impact in

Transplantation top 5%
Oncology top 10%
- Cancer-related Molecular Pathways

Papers in ⓘ

Hematology 9
- Hematopoietic Stem Cell Transplantation 8
- Acute Myeloid Leukemia Research 5
Cancer Research 9
- MicroRNA in disease regulation 4

Co-authors: Carol Prives (1 shared paper)D R Marshak (1 shared paper)Jill Bargonetti (1 shared paper)James J. Manfredi (1 shared paper)Donald Sullivan (1 shared paper)Tim C. Huffaker (1 shared paper)Hua Zhu (1 shared paper)Ron Prywes (1 shared paper)
Journals: Scientific Reports (2 papers)Carcinogenesis (2 papers)Genes & Development (2 papers)PLoS ONE (2 papers)Pharmacology (1 paper)
Partner nations: China United States Australia

In The Last Decade

X Chen

53 papers receiving 1.3k citations

Peers

Countries citing papers authored by X Chen

Since Specialization

Citations

This map shows the geographic impact of X Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by X Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites X Chen more than expected).

Fields of papers citing papers by X Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by X Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by X Chen. The network helps show where X Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside X Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with X Chen Line = papers co-authored together X Chen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein. Genes & Development ·Jill Bargonetti, James J. Manfredi, X Chen, D R Marshak, Carol Prives	1993	229
2	Two yeast genes with similarity to TCP-1 are required for microtubule and actin function in vivo. Proceedings of the National Academy of Sciences ·X Chen, Donald Sullivan, Tim C. Huffaker	1994	116
3	Cooperative DNA binding of p53 with TFIID (TBP): a possible mechanism for transcriptional activation. Genes & Development ·X Chen, George E. Farmer, Hua Zhu, Ron Prywes, Carol Prives	1993	109
4	Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment Journal of Controlled Release ·Tong‐Fei Li, Ke Li, Chao Wang, Xin Liu, Yu Wen, Yong‐Hong Xu, Quan Zhang, Qiu-Ya Zhao, Ming Shao, Yan-Ze Li, Min Ho Han, Naoki Komatsu, Li Zhao, X Chen	2017	77
5	Cardiac endothelial cell-derived exosomes induce specific regulatory B cells Scientific Reports ·Jiangping Song, X Chen, Mangyuan Wang, Yong-Mei Xing, Zhe Zheng, Shengshou Hu	2014	48
6	Upregulation of the ALDOA/DNA-PK/p53 pathway by dietary restriction suppresses tumor growth Oncogene ·Da Ma, X Chen, P-Y Zhang, Haoke Zhang, L-J Wei, Shanshan Hu, J-Z Tang, Mengtao Zhou, Congying Xie, Ruiming Ou, Yang Xu, K-F Tang	2017	47
7	Effects of diltiazem on pharmacokinetics of tacrolimus in relation to CYP3A5 genotype status in renal recipients: from retrospective to prospective The Pharmacogenomics Journal ·JL Li, Xiaodong Wang, Shao‐Yuan Chen, Liu Ls, Qin Fu, X Chen, L-C Teng, Wang Cx, Min Huang	2010	47
8	Metabolic Engineering of Saccharomyces cerevisiae for Rosmarinic Acid Production ACS Synthetic Biology ·Mahsa Babaei, Gheorghe Manuel Borja Zamfir, X Chen, Hanne Bjerre Christensen, Mette Kristensen, Jens Nielsen, Irina Borodina	2020	41
9	The Fra-1–miR-134–SDS22 feedback loop amplifies ERK/JNK signaling and reduces chemosensitivity in ovarian cancer cells Cell Death and Disease ·Jianmin Wu, Yimin Sun, Pei-Ying Zhang, Mengyao Qian, Hengchao Zhang, X Chen, Di Ma, Yunsheng Xu, Xiaohong Chen, Kai‐Fu Tang	2016	39
10	Degradation of endogenous proteins and generation of a null-like phenotype in zebrafish using Trim-Away technology Genome biology ·X Chen, Mi Liu, Hongyan Lou, Yiyi Lu, Mengtao Zhou, Rongying Ou, Yunsheng Xu, Kai‐Fu Tang	2019	32
11	ITE and TCDD Differentially Regulate the Vascular Remodeling of Rat Placenta via the Activation of AhR PLoS ONE ·Yanming Wu, X Chen, Qian Zhou, Qizhi He, Jiuhong Kang, Jing Zheng, Kai Wang, Tao Duan	2014	31
12	Overlapping TATA-dependent and TATA-independent early promoter activities in the baculovirus gp64 envelope fusion protein gene Journal of Virology ·Philip H. Kogan, X Chen, Gary W. Blissard	1995	30
13	Dicer regulates non-homologous end joining and is associated with chemosensitivity in colon cancer patients Carcinogenesis ·X Chen, Wenfeng Li, Xiaoli Wu, Heng‐Chao Zhang, Li Chen, Pei-Ying Zhang, Liyuan Liu, Di Ma, Tongke Chen, Mengtao Zhou, Yunsheng Xu, Mengtao Zhou, Kai‐Fu Tang	2017	29
14	In vivo optical molecular imaging of inflammation and immunity Journal of Molecular Medicine ·Nian Liu, X Chen, Melanie A. Kimm, Matthias Stechele, Xueli Chen, Zhimin Zhang, Moritz Wildgruber, Xiaopeng Ma	2021	28
15	Suprapatellar versus infrapatellar intramedullary nailing for treatment of tibial shaft fractures in adults Medicine ·X Chen, Haitao Xu, Hongjun Zhang, Jing Chen	2018	27
16	Screening Therapeutic Agents Specific to Breast Cancer Stem Cells Using a Microfluidic Single‐Cell Clone‐Forming Inhibition Assay Small ·Dongguo Lin, Pei-Wen Li, Jin Feng, Zhun Lin, X Chen, Na Yang, Lihui Wang, Dayu Liu	2019	26
17	Site-Directed Mutagenesis Improves the Transduction Efficiency of Capsid Library-Derived Recombinant AAV Vectors Molecular Therapy — Methods & Clinical Development ·Gai Ran, X Chen, Yilin Xie, Qingyun Zheng, Jinyan Xie, Chenghui Yu, Nikéa Pittman, Sixian Qi, Fa‐Xing Yu, Mavis Agbandje‐McKenna, Arun Srivastava, Chen Ling	2020	23
18	Oncological results and recurrent risk factors following abdominal radical trachelectomy: an updated series of 333 patients BJOG An International Journal of Obstetrics & Gynaecology ·X Li, Jin Li, Zhaoxia Jiang, Lingfang Xia, Xingzhu Ju, X Chen, Xiaohua Wu	2019	23
19	Dihydroartemisinin inhibits the migration of esophageal cancer cells by inducing autophagy Oncology Letters ·X Chen, Lanying He, Shu Lai, Yao He	2020	22
20	Unexpected role for p19INK4d in posttranscriptional regulation of GATA1 and modulation of human terminal erythropoiesis Blood ·Xu Han, Jieying Zhang, Yuanliang Peng, Minyuan Peng, X Chen, Huiyong Chen, Jianhui Song, Xiao Hu, Mao Ye, Jianglin Li, Vijay G. Sankaran, Christopher D. Hillyer, Narla Mohandas, Xiuli An, Jing Liu	2016	19

About X Chen

X Chen is a scholar working on Hematology, Cancer Research, Aging, Immunology and Oncology, having authored 58 papers that have together received 1.3k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (8 papers), Acute Myeloid Leukemia Research (5 papers), Virus-based gene therapy research (5 papers), Cancer-related Molecular Pathways (5 papers), RNA Interference and Gene Delivery (4 papers), MicroRNA in disease regulation (4 papers), DNA Repair Mechanisms (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Transplantation (49 citations), Oncology (435 citations), Biotechnology (116 citations), Molecular Biology (781 citations) and Cancer Research (168 citations). X Chen has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Carol Prives, D R Marshak, Jill Bargonetti, James J. Manfredi, Donald Sullivan, Tim C. Huffaker, Hua Zhu, Ron Prywes, Carol Prives and George E. Farmer. Their work appears in journals such as Scientific Reports, Carcinogenesis, Genes & Development, PLoS ONE and Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact